METHODS OF TREATING VENOUS VALVE RELATED CONDITIONS WITH A FLOW-MODIFYING IMPLANTABLE MEDICAL DEVICE

• US 20080051879A1
• Filed: 08/23/2007
• Published: 02/28/2008
• Est. Priority Date: 08/23/2006
• Status: Abandoned Application

• Current Assignee: Cook Incorporated (Cook Group Incorporated)
• Original Assignee: Cook Incorporated (Cook Group Incorporated)
• Inventors: Shirley, Gary, Flagle, Jacob, Case, Brian, Paul, Ram
• Application Number:
  US11/844,003
• Publication Number:
  US 20080051879A1
• Time in Patent Office: Days
• US Class Current: 623/1.24
• CPC Class Codes: A61F 2/07 Stent-grafts
• CPC Class Codes: A61F 2/2475 Venous valves
• CPC Class Codes: A61F 2002/068 Modifying the blood flow model, e.g. by diffuser or deflector

Abstract

Implantable medical devices adapted to modify fluid flow within a body vessel are provided herein. The medical devices may include a fluid flow restricting channel configured to reduce longitudinal fluid flow in a retrograde direction or in an antegrade direction. Preferably, the medical devices are flow-modifying devices that reduce fluid flow through the medical device to a greater extent in a retrograde direction than in an antegrade direction. Methods of treatment comprising the step of implanting a flow-modifying medical device within a body vessel are also provided. Flow-modifying devices are useful, for example, in treating venous valve related conditions.

Claims

1. A method of treating a venous valve-related condition by reducing blood flow in a retrograde direction away from a heart in a subject, the method comprising the steps of:

a. inserting a flow-modifying medical device into a body vessel within the deep venous system, the peripheral venous system or the perforating venous system, the flow-modifying medical device including a fluid flow channel extending longitudinally through the flow-modifying device between an inlet and an outlet and configured to restrict a rate of fluid flow therethrough in a retrograde direction from the outlet to the inlet more than a restriction of the rate of fluid flow through the fluid flow channel in an antegrade direction from the inlet to the outlet; and

b. deploying the flow-modifying medical device within the body vessel at a point of treatment to provide a first reduction in the rate of blood flow within the body vessel through the fluid flow channel in the retrograde direction away from the heart while providing a second reduction in the rate of blood flow within the body vessel through the fluid flow channel in the antegrade direction toward the heart that is less than the first reduction.

2. The method of claim 1, wherein the fluid flow channel is configured to restrict the rate of fluid flow therethrough by about 0.5-20% more in the retrograde direction than in the antegrade direction.

3. The method of claim 1, where the fluid flow channel extends along the longitudinal axis including an orifice positioned between the inlet having a first cross-sectional area and the outlet having a second cross-sectional area, the orifice having a third cross-sectional area that is less than the first cross-sectional area;

the fluid flow channel being defined by an antegrade flow receiving surface extending from the inlet to the orifice, and a retrograde flow receiving surface extending from the outlet to the orifice, the antegrade flow receiving surface having a frustoconical cross section in a first radial bisecting plane containing the longitudinal axis.

4. The method of claim 3, wherein the retrograde flow receiving surface has an arcuate cross section in the first plane, the arcuate section having a surface with a first radius of curvature.

5. The method of claim 3, wherein the first reduction in the rate of blood flow in the retrograde direction is about 1-10% more in the second reduction in the rate of blood flow in the antegrade direction after positioning the medical device within the body vessel.

6. The method of claim 3, wherein antegrade flow receiving surface is oriented at an angle of about 20-70 degrees with respect to the longitudinal axis.

7. The method of claim 3, wherein the longitudinal axis passes through the center of the orifice.

8. The method of claim 3, wherein the ratio between the first cross-sectional surface area at the inlet and the third cross-sectional surface area at the orifice is between about 1.0 and 5.0.

9. The method of claim 8, wherein the ratio between the first cross-sectional surface area at the inlet and the third cross-sectional surface area at the orifice is between about 2.0 and 2.5.

10. The medical device of claim 3, wherein the third cross-sectional area of the orifice has a circular configuration with a diameter of at least 3 mm.

11. The method of claim 3, wherein at least a portion of the fluid flow channel is formed by a forming material comprising a biocompatible polyurethane.

12. The method of claim 11, wherein the medical device comprises a radially expandable support frame, and the forming material is attached to the support frame.

13. The method of claim 3, wherein at least a portion of the fluid flow channel is formed by a biodegradable material.

14. A method of treating a venous valve-related condition comprising the steps of:

a. inserting a flow-modifying medical device within a body vessel, the flow-modifying medical device having a longitudinal axis, the flow-modifying medical device comprising an annular bi-directional fluid flow restricting channel extending along the longitudinal axis from an inlet to an outlet, the fluid flow restricting channel including

i. an orifice having a thickness that is less than 10% of a maximum diameter of the orifice, the orifice being substantially parallel to and positioned longitudinally between the inlet and the outlet, the orifice having a first cross-sectional area oriented substantially perpendicular to the longitudinal axis and the inlet having a second cross-sectional area that is greater than the first cross-sectional area; and

ii. an antegrade flow receiving surface extending from the inlet to the orifice, joined at the orifice to a retrograde flow receiving surface extending from the orifice to the outlet, the antegrade flow receiving surface having a frustoconical cross section in a first hypothetical radial bisecting plane containing the longitudinal axis;

the retrograde flow receiving surface having a curved cross section in the hypothetical first radial bisecting plane containing the longitudinal axis;

iii. the rate of fluid flow in an antegrade direction from the inlet through the flow restricting channel toward the outlet being reduced by less than the rate of fluid flow in a retrograde direction from the outlet through the flow restricting channel toward the inlet; and

b. deploying the flow-modifying medical device within the body vessel at a point of treatment to provide a first reduction in the rate of blood flow in the antegrade direction toward a heart that is less than a second reduction in the rate of blood flow in the retrograde direction away from the heart.

15. The method of claim 14, where the frustoconical cross section is angled between about 20°

and 70°

with respect to the longitudinal axis.

16. The method of claim 14, where the ratio of the second cross-sectional area of the inlet to the first cross-sectional area of the orifice is at least about 1.5.

17. The method of claim 14, wherein the inlet and the outlet each have a cross-sectional area of between about 75 mm² and 185 mm² and the ratio between a third cross-sectional area of the outlet and the first cross-sectional area of the orifice is between about 1 and 5.

18. The method of claim 14, wherein the orifice has a first cross-section having a circular configuration with a diameter of at least 3 mm.

19. The method of claim 14, where the flow-modifying medical device is further characterized in that:

a. the flow-modifying medical device includes a self-expanding implantable frame;

b. the retrograde flow receiving surface has an arcuate cross section in the first hypothetical plane;

c. the antegrade flow receiving surface is oriented at an angle of about 20°

-45°

with respect to the longitudinal axis,

d. the rate of fluid flow in the antegrade direction through the flow restricting channel is reduced by about 0.5-20% less than a reduction in the rate of fluid flow in the retrograde direction through the flow restricting channel;

e. the orifice contains the longitudinal axis and is configured as a circle having a diameter of at least 3 mm; and

f. the ratio between the second cross-sectional surface area of the inlet and the cross-sectional area of the first cross-sectional area of the orifice is between about 1.0 and 5.0.

20. A method of treating a venous valve-related condition comprising the steps of implanting a first flow-modifying medical device within a first vein and having a body vessel diameter;

implanting a second flow-modifying medical device within a blood vessel in fluid flow communication with the first vein;

the first flow-modifying medical device and the second flow-modifying medical device each including a fluid flow restricting channel extending between an inlet and an outlet and having a diameter that is less than the body vessel diameter, the flow-modifying medical device being configured to restrict the rate of fluid flow in an antegrade direction from the inlet to the outlet through the fluid flow restricting channel by less than a restriction of fluid flow in an retrograde direction from the outlet to the inlet through the fluid flow restricting channel, wherein

a. the minimum diameter of the flow restricting channel is an orifice having a first diameter that is substantially invariant to changes in fluid flow direction from the antegrade direction to the retrograde direction;

b. the fluid flow restricting channel includes an antegrade flow receiving surface extending form the inlet to the orifice and including an arcuate longitudinal cross section with a radius of curvature;

c. the ratio of the of the radius of curvature to the first diameter of the orifice being between about 0.5 and 0.8.